Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer

ABSTRACT: Interventions: Vaccination Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616208 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR